GlassScriptPhysician profile
Mickey My Tseng
NPI 1073624276
$5,234.63
in general payments reported to CMS, 2019-2025
19 companies · $928 in 2025
The $928 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $113 · 2021: $310 · 2022: $2,304 · 2023: $340 · 2024: $965 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,650 · Travel and Lodging: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,650.21 |
| Travel and Lodging | $583.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,625.32 | 2022 | |
| Ortho Development Corporation | $1,158.36 | 2019-2025 | |
| Stryker Corporation | $602.38 | 2024 | Iconix, Omega |
| Orthalign INC | $356.06 | 2024-2025 | Orthalign Plus |
| Heraeus Medical, LLC. | $186.50 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $180.22 | 2022 | |
| Amgen INC. | $170.86 | 2021-2023 | Prolia, Evenity |
| Grt US Holding, INC. | $150.00 | 2022 | |
| Janssen Scientific Affairs, LLC | $138.25 | 2023 | Xarelto |
| Next Science LLC | $114.11 | 2024 | Xperience, Blastx, Surgx |
| Orthogrid Systems INC | $112.50 | 2020 | |
| Smith+Nephew, INC. | $86.83 | 2019 | |
| Encore Medical, LP | $80.78 | 2022 | |
| Averitas Pharma INC. | $65.96 | 2024 | Qutenza |
| Collegium Pharmaceutical, INC. | $54.41 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nextstep Arthropedix, LLC | $51.98 | 2019 | |
| Sanara Medtech INC. | $46.10 | 2025 | Biasurge |
| Scilex Pharmaceuticals INC. | $34.00 | 2024 | |
| Idorsia Pharmaceuticals US INC | $20.01 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mickey Tseng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.